Voya Investment Management LLC Magenta Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $11,531 - $36,615	-11,888 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $2,241 - $4,214	-506 Reduced 4.08%	11,888 $53,000
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $22,526 - $32,658	2,308 Added 22.88%	12,394 $121,000
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $61,524 - $80,082	10,086 New	10,086 $79,000
Q4 2018 Feb 14, 2019	SELL	$5.57 - $11.65 $1.39 Million - $2.9 Million	-248,804 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $24,145 - $33,488	-2,133 Reduced 0.85%	248,804 $2.99 Million
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $3.39 Million - $3.64 Million	250,937 New	250,937 $3.39 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.